Mytrex Health Technologies (ROCO:4431) EBIT : NT$-39 Mil (TTM As of Jun. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Mytrex Health Technologies EBIT?

Mytrex Health Technologies's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2024 was NT$-6 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was NT$-39 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Mytrex Health Technologies's annualized ROC % for the quarter that ended in Jun. 2024 was -8.32%. Mytrex Health Technologies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -4.29%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Mytrex Health Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -6.31%.

Mytrex Health Technologies EBIT Historical Data

The historical data trend for Mytrex Health Technologies's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mytrex Health Technologies EBIT Chart

Mytrex Health Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

7.67

442.62

-12.02

-56.62

-50.94

Mytrex Health Technologies Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EBIT	Get a 7-Day Free Trial															-2.01	-54.61	-17.97	-32.98	-6.39

Competitive Comparison of Mytrex Health Technologies's EBIT

For the Specialty Industrial Machinery subindustry, Mytrex Health Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mytrex Health Technologies's EV-to-EBIT Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Mytrex Health Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Mytrex Health Technologies's EV-to-EBIT falls into.

Mytrex Health Technologies EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-39 Mil.

Mytrex Health Technologies (ROCO:4431) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Mytrex Health Technologies's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

	ROC % (Q: Jun. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Jun. 2024 ))	/ count )
=	-65.014 * ( 1 - 5.89% )	/	( (812.296	+	659.066)	/ 2 )
=	-61.1846754	/	735.681
=	-8.32 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1258.189	-	215.711	-	( 240.749	-	max(0, 441.752	-	671.934	+	240.749	))
=	812.296

	Invested Capital		(Q: Jun. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1326.511	-	353.972	-	( 347.963	-	max(0, 539.405	-	852.878	+	347.963	))
=	659.066

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Mytrex Health Technologies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jun. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Jun. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-12.77	/	( ( (241.143 + max(148.133, 0))	+	(168.065 + max(37.909, 0)) )	/	2 )
=	-12.77	/	( ( 389.276	+	205.974 )	/	2 )
=	-12.77	/	297.625
=	-4.29 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(158.742	+	203.222	+	22.284)	-	(215.711	+	0	+	20.404)
=	148.133

	Working Capital		(Q: Jun. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(162.192	+	212.831	+	77.516)	-	(353.972	+	0	+	60.658)
=	37.909

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Mytrex Health Technologies's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jun. 2024 )
	=	-39.36	/	623.908
	=	-6.31 %

Mytrex Health Technologies EBIT Related Terms

Thank you for viewing the detailed overview of Mytrex Health Technologies's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Mytrex Health Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Mytrex Health Technologies Inc (ROCO:4431) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 545, Section 2, Hezhen North Road, Zhongli District, Taoyuan, TWN, 32060

Website

https://www.mytrex.com.tw

Mytrex Health Technologies Inc is a Taiwan-based company engaged in the manufacturing of non-woven materials and special medical supplies. It is engaged in the development and production of melt-blown products for the protection of the environment and human health. The company offers products ranging from medical to industrial filtration materials such as various types of filtration media, lab coats or outfits, cabin filtration, vacuum cleaner filter bags, and special medical supplies. Its product categories include meltdown, mammoth bedding, and specialized medical supplies like balloon catheters and coronary stents.

Mytrex Health Technologies Headlines

No Headlines